Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study

Autor: Fisher, Benjamin A, Mariette, Xavier, Papas, Athena, Grader-Beck, Thomas, Bootsma, Hendrika, Ng, Wan-Fai, van Daele, P L A, Finzel, Stephanie, Noaiseh, Ghaith, Elgueta, Sergio, Hermann, Josef, McCoy, Sara S, Akpek, Esen, Bookman, Arthur, Sopala, Monika, Montecchi-Palmer, Michela, Luo, Wen-Lin, Scheurer, Cornelia, Hueber, Wolfgang, Maid, Pablo, Rillo, Oscar, Inderjeeth, Charles, Scheinecker, Clemens, Hermann, Josef, Marcolino, Flora Maria D'Andrea, Dias, Laiza H, Scafuto, Antonio, Bookman, Arthur AM, Fortin, Isabelle, Morin, Frederic, Goio, Elizabeth Jean Moreno, Pezo Ruiz, Ninette, Roman Zamoran, Carlos Patricio, Gonzalez Abarzua, Ivan Antonio, Elgueta, Sergio Fabian, Forero Illera, Elias Gonzalo, Marquez Herndez, Javier Dario, Garcia, Alex Echeverri, Pensec, Valerie Devauchelle, Hachulla, Eric, Mariette, Xavier, Gottenberg, Jacques-Eric, Le Guern, Veronique, Finzel, Stephanie, Schaefer, Valentin, Tony, Hans-Peter, Thomas Schmalzing, Marc, Tausche-Wunderlich, Anne-Kathrin, Tzioufas, Athanasios, Balog, Attila, Rojkovich, Bernadette, Varga, Tunde, Lidar, Merav, Rosner, Itzhak, Levy, Yair, Dagna, Lorenzo, Mosca, Marta, Quartuccio, Luca, Nishiyama, Susumu, Kodera, Masanari, Kaneko, Yuko, Okada, Masato, Ueki, Yukitaka, Hwan Park, Sung, van Daele, Paulus Leon Arthur, Bootsma, Hendrika, Duarte Barcelos, Filipe Alexandre, Crispim Romao, Vasco Madeira, Raimundo Vinagre, Filipe Manuel, Tavaresda Costa, Jose Antonio, Rednic, Simona, Duca, Liliana, Maslyanskiy, Alexey, Yakupova, Svetlana, Bugrova, Olga, Izmozherova, Nadezhda, Zotkin, Evgenyi, Nikolaevna Anoshenkova, Olga, Kvarnstrom, Marika, Tufan, Abdurrahman, Fisher, Benjamin, Yee, Chee Seng, Parker, Benjamin Joseph, Grader Beck, Thomas, Lawrence Ford, Theresa, Papas, Athena, Carsons, Steven, Thiagarajan, Saravanan, Zero, Domenick, McCoy, Sara, Sandorfi, Nora

Publikováno v: The Lancet; August 2024, Vol. 404 Issue: 10452 p540-553, 14p

Is the reason to switch relevant?

Autor: Manica, Santiago Rodrigues, Sepriano, Alexandre, Pimentel-Santos, Fernando, Gouveia, Nélia, Barcelos, Anabela, Branco, Jaime C., Bernardes, Miguel, Ferreira, Raquel Miriam, Vieira-Sousa, Elsa, Barreira, Sofia, Vinagre, Filipe, Roque, Raquel, Santos, Helena, Madeira, Nathalie, Rovisco, João, Daniel, Alexandra, Ramiro, Sofia

Publikováno v: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP

57763]. AS is supported by a doctoral grant from “Fundação para a Ciência e Tecnologia” (SFRH/BD/108246/2015). Background: To investigate whether the reason to discontinue the first TNF inhibitor (TNFi) affects the response to the second TNFi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a63da268e4438fe28dcee13589ac9162

going beyond BASDAI

Autor: Marona, Jose, Sepriano, Alexandre, Rodrigues-Manica, Santiago, Pimentel-Santos, Fernando, Mourão, Ana Filipa, Gouveia, Nélia, Branco, Jaime Cunha, Santos, Helena, Vieira-Sousa, Elsa, Vinagre, Filipe, Tavares-Costa, João, Rovisco, João, Bernardes, Miguel, Madeira, Nathalie, Cruz-Machado, Rita, Roque, Raquel, Silva, Joana Leite, Marques, Mary Lucy, Ferreira, Raquel Miriam, Ramiro, Sofia

Publikováno v: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP

This work was supported by a Research Grant from the InvestigatorInitiated Studies program of Merck Sharp & Dohme (Grant No. 56078). The sponsor did not interfere with the study question, analysis or interpretation of results. AS is supported by a do

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4324464cf5abd23685dc739a40817219

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE

Autor: Vieira-Sousa, Elsa, Machado, Pedro M., Costa, Jose, Ribeiro, Ana, Aguiar, Renata, Cerqueira, Marcos, Neto, Adriano, Bernardo, Alexandra, Cordeiro, Ana, Duarte, Catia, Vinagre, Filipe, Canhao, Helena, Santos, Helena, Neves, Joana Sousa, Cunha-Miranda, Luis, Silva, Margarida, Santos, Maria Jose, Bernardes, Miguel, Bogas, Monica, Pedro Machado, Queiroz, Mario Viana, Barros, Rita, Falcao, Sandra, Pimenta, Sofia, Teixeira, Vitor, Fonseca, Joao Eurico, Barcelos, Anabela

Publikováno v: Publons

To update recommendations for the treatment of psoriatic arthritis with biological therapies, endorsed by the Portuguese Society of Rheumatology (SPR).These treatment recommendations were formulated by Portuguese rheumatologists based on literature e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0a9004996a61976722be26575de9fc41
https://pubmed.ncbi.nlm.nih.gov/26610694